Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C107555
http://purl.obolibrary.org/obo/NCIT_C107555
|
|---|---|
| Preferred Name | Bufalin |
| Definitions |
An active ingredient and one of the glycosides in the traditional Chinese medicine ChanSu; it is also a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans, with potential cardiotonic and antineoplastic activity. Although the mechanism of action of bufalin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and can induce apoptosis in cancer cell lines through the activation of the transcription factor AP-1 via a mitogen activated protein kinase (MAPK) pathway.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An active ingredient and one of the glycosides in the traditional Chinese medicine ChanSu; it is also a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans, with potential cardiotonic and antineoplastic activity. Although the mechanism of action of bufalin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and can induce apoptosis in cancer cell lines through the activation of the transcription factor AP-1 via a mitogen activated protein kinase (MAPK) pathway. |
|---|---|
| label | Bufalin
|
| prefLabel | Bufalin
|
| in_subset |
See more
See less
|
| Preferred_Name | Bufalin
|
| Is_Value_For_GDC_Property | |
| Display_Name | Bufalin
|
| Maps_To | Bufalin
|
| UMLS_CUI | C0054205
|
| FDA_UNII_Code | U549S98QLW
|
| prefixIRI | NCIT:C107555
|
| Contributing_Source |
CTRP
FDA
|
| subClassOf | |
| code | C107555
|
| type | |
| Semantic_Type | Pharmacologic Substance
|
| CAS_Registry | 465-21-4
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |